Cardiovascular Trials Review Cardiovascular Trials Review - Diegori.it

Page
Acronym/Title
1091 PREVENT (Post Hoc Analysis) – Prospective Randomized Evaluation
of the Vascular Effects of Norvasc Trial
1093 PART-2 – Prevention of Atherosclerosis with Ramipril Trial-2
1095 PPP – Primary Prevention Project
1098 SECURE – Study to Evaluate Carotid Ultrasound Changes in Patients
Treated with Ramipril and Vitamin E
1100 DAIS – Diabetes Atherosclerosis Intervention Study
1102 ETICA – Exercise Training Intervention After Coronary Angioplasty
1104 MORE – Multiple Outcomes of Raloxifene Evaluation (Secondary
Analysis)
1106 CLARIFY – Clarithromycin Acute Coronary Syndrome Patients in
Finland
1108 ADAM – Aneurysm Detection and Management Veterans Affairs
Cooperative Study
1110 United Kingdom Small Aneurysm Trial Participants
1112 TPT (Angina) – Thrombosis Prevention Trial
1114 CUDAS – Perth Carotid Ultrasound Disease Assessment Study
1116 CAPRIE – Clopidogrel versus Aspirin in Patients at Risk of Ischemic
Events (Substudy)
1118 ELSA – European Lacidipine Study on Atherosclerosis
1121 ENCORE I – Evaluation of Nifedipine and Cerivastatin on Recovery of
Coronary Endothelial Function
1124 Women’s Health Initiative Observational Study
1127 VEAPS – The Vitamin E Atherosclerosis Prevention Study
1129 WAVE – Women’s Angiographic Vitamin and Estrogen Trial
1132 Indo-Mediterranean Diet Heart Study
1134 SUAVIS–Arterial Arm – Sulodexide Arterial Venous Italian Study—
Arterial Arm
1136 PACIFIC – Prevention with a Combined Inhibitor and Folic Acid in
Coronary Heart Disease
1138 HERS II – Heart and Estrogen/Progestin Replacement Substudy
1140 HERS II – Heart and Estrogen/Progestin Replacement Study Follow-up
1142 WHI – Women’s Health Initiative
xxx
Contents